Byotrol Share Discussion Threads

[sikhthetech] 10/12/2023 22:21

The company has made it clear that they are serverly short of cash.
There are also reports of them delisting.

The CEO walked with immediately. No reasons, which suggest skeletons


1gw, you really ought to be ashamed of yourself, knowing full well that the CEO walked, they have a severe cash crisis and there are suggestions of them delisting. Yet you are clearly misleading readers, hoping to entice them in with your stories so you can sell.

Reads can look at TLY, which 1gw and his mates have been deramping for months. Yet none of his stories have actually come true.





Given you portray yourself as well researched poster, why do virtually all your stories across different share fail. Why do virtually all your shares crash?
You make a dodgy 2nd hand car salesman sound honest.

How many multiple ids do you have and why?

sikhthetech - 27 Sep 2023 - 13:14:22 - 11821 of 12373
I think what's really concerning is that VP jumped ship just 4 days before H1 end. It's unusual for CEO/CFO to jump ship immediately.

There was rthm, which 1gw and his mates were ramping them at 500p(new money), where the CFO jumped ship immediately and there were 2 CFOs and 3 CEOs within a short period of tme. I saw that as huge red flags, whereas 1gw and his mates continued to post a good story!!.

The shares crashed which vindicated my and other bears comments.



Last year they had emergency fundraising in August. Maybe VP jumped ship because there were plans for another emergency fund raising.


1gw portrays himself as a well researched poster. Begs the question then why do the vast majority of his shares crash? Why doesn't he and his mates spot the obvious red flags? Why does he post as discodave(several variationsof that id)

[1gw] 09/12/2023 16:24

And if IRI is to succeed in selling on byotrol24, to whom might it sell? My own favourite candidate would be P&G, I think. They've had great success, it would appear, with Microban 24 (licensed from Barr Brands) but they must be concerned about loss of share in the residual disinfection category as other big companies start to bring the Actizone technology to market with its superior technology. They also have experience with promoting someone else's brand (microban) and so might even be prepared to retain the byotrol24 brand in order to use the existing registrations to bring the product to market quickly. That might enable them to get ahead of other companies in promoting residual virucidal claims, as Actizone doesn't appear yet to have got these claims registered with the EPA.

[bagsandbags] 09/12/2023 16:14

Use your loaf, er loaf. How can they announce anything that they haven’t signed? Or give a blow by blow of negotiations? I thought in all this type of stuff the companies involved need the other’s approval to mention anything about them. And no-one would ever give it.
Imv all they can do is report in guidance what they think will happen. I agree 100% with your frustration on where we are, but I don’t think your rant is right this time. We have no choice but to wait it out or give up and sell.

[1gw] 09/12/2023 15:17

I suppose another point about an onward sale by IRI is that it might provide IRI with surplus cash with which to settle the outstanding amounts on the $1.4m due to byotrol (over 4 years to Feb 2026) for the sale of byotrol24 rights to IRI.

So that one event (onward sale) might effectively provide the bulk of both the FY24 £0.8m IP income and the acceleration of guaranteed cash. That would be a big announcement, were it to happen.

[bagsandbags] 09/12/2023 14:39

1gw -
I was hoping they would do an IMC and was going to ask the question about Integrated. The way VP explained it was not at all as I understood it. I thought Integrated were making payments to buy the formulation (now in the Byot balance sheet as receivables), plus a small royalty on their sales, plus an extra kicker to Byot if they sell the formulation on at some point. So I was really surprised when he talked about milestones and 'several third parties' - it doesn't match at all what the company had said before or since.
I was hoping that Integrated would indeed sell as their licensee launches, as it will then be a proven product (finally) so therefore more valuable. But thats obv not going to happen until we see some product in market

[1gw] 09/12/2023 12:24

And then of course, there is the prospect of material Actizone commission or other royalty coming in which, while continually seeming to disappear over the horizon, may at some point come in. From the interims:

"Commission and royalties are now expected to be material to our finances from FYE March 2024"
"recent projections suggest [Actizone commissions] will become financially material to Byotrol by FYE 2025"

I believe Clorox are ready to go (in terms of having EPA plus all state registrations) with their new Disinfecting Mist/Multi-surface cleaner product ("Advanced" on the labels) which I think is Actizone-based and could well be launched in 1Q (yes, lot's of speculation here). And SC Johnson seem to be working their way through State registrations at a reasonable pace for their Actizone product, so conceivably that could launch in byotrol's FY25.

[1gw] 09/12/2023 12:14

For those of us who feel locked in here and still want to speculate about how things might get better, we can think about the £0.8m of IP income that has been left in the Cavendish forecast for this financial year (i.e. by end-March).

I continue to think that minimum guaranteed payments on the IRI/USCo deal might be made unconditional by some event such as final state (i.e. California) approval for Ecolab.

But if it's not that then could it be on-sale by IRI of the byotrol24 rights? Byotrol have given us some additional detail on the IRI agreement in the interims. When the initial sale deal was announced (October 2021) they said:
"three years of royalty on all IRI sales; further payments to Byotrol should IRI onward sell the Formulation within 3 years"
In the interims they say:
"low single-digit royalties and a material percentage of the additional sales proceeds should IRI onward sell the formulation. "

So they have given us the "low single-digit" quantification of royalty level (excluding I presume royalties on the later IRI-USCo-byotrol 3-way deal announced in 2022) and also given us "material percentage" quantification relating to onward sell.

IRI still have not even updated their byotrol24 website with details of the May 2023 additional EPA registration, something byotrol felt important enough to RNS. So I think it is a realistic possibility that IRI is trying to close a sale of the remaining rights (principally for consumer sales, presumably, given the exclusivity with USCo on professional sales).

And if it is neither of those, then there's always VPs words at the last IMC session, which referred to multiple IRI licensees seeking EPA approval with milestone payments and minimum guarantees.

"You may have read in our RNS that Integrated has secured its EPA approval in the US which is a great milestone. Now Integrated's actual sales themselves are not very large however they have licensed it to several third parties who are in the process of getting EPA approval. Once they have that EPA approval, it will trigger some milestone payments as well as minimum guarantees and royalty payments."

I suspect there was some mis-speak here, but you never know.

[1gw] 08/12/2023 18:44

I don't know football. It's an interesting thought. In theory they've just given us a pretty complete dump of the state of the business. This includes guiding (via Cavendish) £0.8m of IP income in 2H.

Now if directors are aware of where that £0.8m is expected to come from and how advanced the relevant negotiations are (or what the triggering event is if it is milestone-based, such as a state registration or a product launch decision), is that inside information which would prevent them from buying? Or is it just detail and the fact that the £0.8m has been published means knowledge of the underlying transaction is not sufficient to prevent them buying?

[football] 08/12/2023 15:41

Could there be no board buys so far because they have a deal in the pipeline has any half decent board member would have been buying yesterday to show faith in the results

[sikhthetech] 08/12/2023 13:16

1gw

"how much of today's buying was by directors or PDMRs?"

a 100k trade is only £500-£600 and you're suggesting directors are buying!!!

desperation

[1gw] 08/12/2023 10:27

New pathogen profile on feline coronavirus, with plugs for Anigene and Invirtu.

I had missed the stories on Fcov-23 but scary potential (for cats) if it gets established.

[1gw] 08/12/2023 09:50

No director purchases (so far), no Investor Meet Company presentation, acknowledgement of "potentially a modest fundraise" and a suggestion also that they are keeping the decision to remain listed under frequent review.

Hardly an encouraging background for retail investors to buy, is it?

[football] 08/12/2023 08:40

So with no board buys yesterday it seems the market must have liked the RNs then and been buying instead

[1gw] 07/12/2023 16:40

So, how much of today's buying was by directors or PDMRs?

[sikhthetech] 07/12/2023 13:15

In terms of Tristel, they stated their position over 3 years ago.

Why would they want to take over the company only to go through the hassle of getting rid of parts of the business which they have no interest in? Let someone else do that and they might be interested.

[sikhthetech] 07/12/2023 13:11

Not good. The newsflow here has been as predicted.

CEO walking immediately was the big red flag.
They didn't seize the big opportunity presented to them when the biggest pandemic in 100yrs hit. That was the big warning of the problems they faced.

They desperately need cash. And only recently announced they need someone to cover maternity leave.

Delisting will save listing fees but won't address the core problems.
For how long will the money they save on listing fees last???

It'll be extremely difficult to get funding whilst they are delisted.

The 'good' thing about being delisted is that they won't need to inform the market as to why VP left immediately. So skeletons will remain the unknown.



sikhthetech - 27 Sep 2023 - 13:14:22 - 11821 of 12373
I think what's really concerning is that VP jumped ship just 4 days before H1 end. It's unusual for CEO/CFO to jump ship immediately.

There was rthm, which 1gw and his mates were ramping them at 500p(new money), where the CFO jumped ship immediately and there were 2 CFOs and 3 CEOs within a short period of tme. I saw that as huge red flags, whereas 1gw and his mates continued to post a good story!!.

The shares crashed which vindicated my and other bears comments.



Last year they had emergency fundraising in August. Maybe VP jumped ship because there were plans for another emergency fund raising.


1gw portrays himself as a well researched poster. Begs the question then why do the vast majority of his shares crash? Why doesn't he and his mates spot the obvious red flags? Why does he post as discodave(several variationsof that id)

[best1467] 07/12/2023 12:29

Plus they just. Just-departed animal health

[piedro] 07/12/2023 11:18

football,
Why would someone like Tristel wish to buy such a looser?
Particularly now that they are bedded down with MediChem.

[mudbath] 07/12/2023 11:15

Byotrol's decimated share price reflects the significant possibility that a delisting lies ahead.
When/if announced the share price could well implode even further.
Therein would lie the main opportunity.

[maxk] 07/12/2023 11:04

I'm not sure how going private would help us private punters.

What is there to gain?

[football] 07/12/2023 11:01

maybe best option is if someone like Tristel bought us with shares rather than cash and we become part of them

[cliffpeat] 07/12/2023 10:54

Speculation and maybe just a negative state of mind

re: Delisting option

It might explain:

1. Strangely low share price despite hardly any share transactions
2. Possible sale when private - surely that would not already be being negotiated? [Edit - sarcasm]
3. No director buys
4. CEO resignation
5. Resolutions on 25 Sep23
6. NED appointment

Would be very disappointing if this turns out to be anything near what happens.

DYOR